Screening

Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.

Microsoft and Bristol Myers Squibb partner to advance AI-enabled lung cancer detection
Lung cancer remains the leading cause of cancer-related deaths in the United States. It is estimated that it claims approximately 125,000 lives in the U.S. every year.
FDA clears opportunistic AI for detecting cardiothoracic issues in CT scans
“Coronary calcium revealed long ago that atherosclerosis begins well before symptoms. AI-CVD extends that insight by enabling systematic identification of patients who are unaware of their cardiovascular risk using CT scans that already exist,” said Arthur Agatston, MD.
CT colonography the most cost-effective cancer screening option for many
Findings from the Neiman Health Policy Institute and Northwell Health indicate that CTC is especially beneficial for underserved populations.
Beyond just nodules—model uses all low-dose CT data to make long-term lung cancer risk predictions
New findings published in RSNA's Radiology highlight the shortcomings of using nodule characteristics and patient history alone to predict an individual’s true cancer risk.
How one hospital more than doubled its lung cancer screening rate
It is estimated that less than 20% of eligible patients in the U.S. adhere to LCS recommendations, despite numerous studies highlighting the exam’s effectiveness.

Microsoft and Bristol Myers Squibb partner to advance AI-enabled lung cancer detection

Lung cancer remains the leading cause of cancer-related deaths in the United States. It is estimated that it claims approximately 125,000 lives in the U.S. every year.

The U.S. Food and Drug Administration (FDA) has cleared HeartLung Corporation's AI-CVD, an artificial intelligence (AI) algorithm that looks at 11 different opportunistic health screening assessments on chest CT exams ordered for any reason.

FDA clears opportunistic AI for detecting cardiothoracic issues in CT scans

“Coronary calcium revealed long ago that atherosclerosis begins well before symptoms. AI-CVD extends that insight by enabling systematic identification of patients who are unaware of their cardiovascular risk using CT scans that already exist,” said Arthur Agatston, MD.

CT colonography the most cost-effective cancer screening option for many

Findings from the Neiman Health Policy Institute and Northwell Health indicate that CTC is especially beneficial for underserved populations.

Beyond just nodules—model uses all low-dose CT data to make long-term lung cancer risk predictions

New findings published in RSNA's Radiology highlight the shortcomings of using nodule characteristics and patient history alone to predict an individual’s true cancer risk.

How one hospital more than doubled its lung cancer screening rate

It is estimated that less than 20% of eligible patients in the U.S. adhere to LCS recommendations, despite numerous studies highlighting the exam’s effectiveness.

Using chest X-rays for triage could reduce lung cancer overdiagnoses

Chest X-rays could be the key to mitigating the issue of overdiagnosis in certain patient populations undergoing lung cancer screening, according to new research.

AI algorithm effectively repurposes CT scans to screen for 2 key chronic diseases

Experts are hopeful that routine CT scans could serve the dual purpose of screening patients for both osteoporosis and heart disease.

The universal screening of children for familial hypercholesterolemia can save lives

If familial hypercholesterolemia is not detected and treated early, it can lead to premature heart attacks and heart disease in young patients.